Trial Profile
A Phase 1 Open Label, Randomized, Two-Way Crossover Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytisinicline (Primary)
- Indications Smoking withdrawal
- Focus Pharmacokinetics
- Sponsors Achieve Life Sciences
- 27 Sep 2018 Results published in an Achieve Life Sciences Media Release
- 27 Aug 2018 Status changed from recruiting to completed.
- 02 May 2018 New trial record